Preclinical evaluation of cyclin dependent kinase 11 and casein kinase 2 survival kinases as RNA interference targets for triple negative breast cancer therapy


1 Research Service (151), Minneapolis VA Health Care System, One Veterans Drive, Minneapolis 55417, MN, USA

2 Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, USA

3 Department of Urology, University of Minnesota, Minneapolis, MN, USA

4 Masonic Cancer Center, University of Minnesota, Minneapolis MN, USA

5 GeneSegues Inc, Chaska, MN, USA

6 Minnesota Supercomputing Institute, University of Minnesota, Minneapolis, MN, USA